Skip to main content

Table 1 Baseline characteristics of hypertensive patients with no cognitive impairment and cognitive function decline

From: Physical activity, sleep disorders, and type of work in the prevention of cognitive function decline in patients with hypertension

Variables

NCI(n = 602)

CFD(n = 131)

P-value

Age, years

65.90 ± 10.49

76.07 ± 7.80

 < 0.001*

Sex (Male), n (%)

293.00(48.67)

63.00(48.09)

0.904

Smoking, n (%)

92.00(15.28)

11.00(8.40)

0.040*

Drinking, n (%)

111.00(18.44)

18.00(13.74)

0.201

Marital status, n (%)

  

0.202

 Married

589.00(97.84)

125.00(95.42)

 

 Unmarried, divorced or widowed

13.00(2.16)

6.00 (4.58)

 

Educational level, n (%)

  

0.048*

 Primary school or below

230(38.21)

65.00(49.61)

 

 Junior high school or senior high school

336.00(55.81)

61.00(46.56)

 

 University or above

36.00(5.98)

5.00(3.82)

 

Type of work, n (%)

  

 < 0.001*

 Manual labor

295.00(49.00)

99.00(75.57)

 

 Mental labor

97.00(16.11)

4.00(3.05)

 

 Both manual and brain labor

210.00(34.88)

28.00(21.37)

 

 Obesity

269(44.7)

70(53.4)

0.069

 Waist circumference, cm

82.78 ± 15.64

87.30 ± 12.65

 < 0.001*

 BMI, kg/m2

24.76 ± 3.26

25.38 ± 3.11

0.049*

 MMSE score, points

29.24 ± 1.00

22.48 ± 3.63

 < 0.001*

 Average salt intake per month, g

300.00[180.00, 600.00]

270.00[180.00, 450.00]

0.051

Imaging parameters

 LVD (mm)

47.13 ± 6.57

49.02 ± 5.71

0.002*

 RVD (mm)

21.91 ± 3.00

22.47 ± 3.87

0.066

 LAD (mm)

36.39 ± 5.76

38.92 ± 6.55

 < 0.001*

 RAD (mm)

32.77 ± 5.60

34.91 ± 6.51

 < 0.001*

Medication information, n (%)

 ACEI/ARBs use

394.00(65.45)

69.00(52.00)

0.006*

 Beta-blockers use

125.00(20.76)

17.00(13.00)

0.041*

 CCBs use

364.00(60.47)

81.00(61.83)

0.772

 Diuretics use

113.00(18.77)

24.00(18.32)

0.905

  1. Data are presented as mean ± SD, median [IQR] or n(%)
  2. Abbreviations: NCI no cognitive impairment, CFD cognitive function decline, BMI body mass index, MMSE mini-mental state examination, RAD right atrial diameter, LAD left atrial diameter, RVD right ventricular diameter, LVD left ventricular diameter, ACEI angiotensin converting enzyme inhibitors, ARB angiotensin receptor blocker, CCBs calcium channel blockers
  3. *Statistically significant value (p < 0.05)